Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$201,014
+$63,706 QoQ
Shares Held
14,846
-35.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#234
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $371,290,075 across 10 Drug Manufacturers - General names. OGN ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,318 | $108,330,127 | |
| 2 | JNJ |
Johnson & Johnson
|
265,811 | $67,508,019 | |
| 3 | ABBV |
AbbVie Inc.
|
206,756 | $52,028,079 | |
| 4 | AMGN |
Amgen Inc
|
109,431 | $39,627,153 | |
| 5 | MRK |
Merck & Co., Inc.
|
273,534 | $35,149,119 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
264,468 | $33,412,887 | |
| 7 | PFE |
Pfizer Inc
|
635,140 | $15,294,171 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
228,360 | $13,158,103 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $201,014 | 14,846 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $137,308 | 22,923 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $233,469 | 32,562 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $225,102 | 21,077 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $228,235 | 23,578 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $323,574 | 21,731 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $337,594 | 22,627 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $410,013 | 21,433 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $409,197 | 19,768 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $516,868 | 27,493 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $535,976 | 37,169 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $793,890 | 45,731 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $818,498 | 39,332 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $808,476 | 34,374 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $915,712 | 32,786 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $511,290 | 21,850 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $433,282 | 12,838 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $696,469 | 19,939 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,177,197 | 38,660 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,006,718 | 30,702 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $209,883 | 6,936 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||